Status:
TERMINATED
The Impact of Vitamin D on Disease Activity in Crohn's Disease
Lead Sponsor:
University of Saskatchewan
Collaborating Sponsors:
Dania Alrefai
Dr.Jennifer Jones
Conditions:
Crohn Disease
Eligibility:
All Genders
16-70 years
Phase:
NA
Brief Summary
The purpose for this study is to determine the effect of vitamin D supplementation on disease activity in Crohn's disease patients in Canada and Saudi Arabia
Detailed Description
Hypothesis 1: Patients who are suffering from Crohn's disease are at risk of vitamin D deficiency. To determine vitamin D status and disease activity in Crohn's disease cases in Canada and Saudi Arab...
Eligibility Criteria
Inclusion
- newly diagnosis with an active Crohn's disease,
- age above of 16 years
Exclusion
- remission or the duration of disease is more than 2 years,
- pregnancy,
- liver or kidney failure,
- inability to take oral supplements or medicine
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT01864616
Start Date
July 1 2013
End Date
March 1 2015
Last Update
May 14 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
IBD clinic; Royal University Hospital
Saskatoon, Saskatchewan, Canada
2
Internal Medicine Department; King Abdulaziz University Hospital
Jeddah, Saudi Arabia